Geftilon 250 mg Tablet

Geftilon 250 mg Tablet contains gefitinib 250 mg, a targeted anticancer medicine used mainly for non-small cell lung cancer. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Gefitinib blocks EGFR signals that can promote the growth and spread of cancer cells.

BUY NOW

Geftilon 250 mg Tablet is indicated for adults with locally advanced or metastatic non-small cell lung cancer with activating EGFR mutations. Gefitinib belongs to the tyrosine kinase inhibitor class and specifically targets epidermal growth factor receptor signaling involved in cancer-cell growth. The medicine is taken under the supervision of an oncologist according to the prescribed treatment schedule. Regular medical follow-up may be required to monitor treatment response and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer Celon Laboratories Ltd

Product Also Known As

Geftilon 250 mg Tablet, Geftilon 250 Tablet, Geftilon Gefitinib Tablet, Gefitinib 250 mg Tablet, Gefitinib Lung Cancer Tablet, Gefitinib EGFR Inhibitor Tablet